(Q30328537)

18 June 2017

1 reference

title

Inactivation of infectious pathogens in labile blood components: meeting the challenge. (English)

1 reference

18 June 2017

Corash L

1

1 reference

PubMed ID

11499954

18 June 2017

language of work or name

1 reference

1 June 2001

1 reference

Transfusion Clinique et Biologique

18 June 2017

1 reference

18 June 2017

8

1 reference

18 June 2017

3

1 reference

18 June 2017

138-145

1 reference

Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries

18 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Transfusion-associated acute Chagas disease acquired in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Transfusion-associated Trypanosoma cruzi infection in a non-endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Transfusion-transmitted babesiosis: a case report from a new endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Reports of 355 transfusion-associated deaths: 1976 through 1985.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Septic reactions to platelet transfusions. A persistent problem

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

A prospective study of symptomatic bacteremia following platelet transfusion and of its management

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Inactivation of viruses in labile blood derivatives. I. Disruption of lipid-enveloped viruses by tri(n-butyl)phosphate detergent combinations

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

The role of the plasma from platelet concentrates in transfusion reactions

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Survey of transfusion-associated graft-versus-host disease in immunocompetent recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Psoralens and related compounds in the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Photochemical decontamination of blood components containing hepatitis B and non-A, non-B virus

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Selective inactivation of viruses in the presence of human platelets: UV sensitization with psoralen derivatives.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Photochemical inactivation of bacteria and HIV in buffy-coat-derived platelet concentrates under conditions that preserve in vitro platelet function

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

A randomized trial of solvent/detergent-treated and standard fresh-frozen plasma in the coagulopathy of liver disease and liver transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Clotting factors in cryoprecipitate and cryo-supernatant prepared from MB-treated fresh plasma.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Clinical tolerance of methylene blue virus-inactivated plasma. A randomized crossover trial in 12 healthy human volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Selective protection against IgG binding to red cells treated with phthalocyanines and red light for virus inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Virus inactivation in red cell concentrates by photosensitization with phthalocyanines: protection of red cells but not of vesicular stomatitis virus with a water-soluble analogue of vitamin E.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Preservation of red cell properties after virucidal phototreatment with dimethylmethylene blue

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Photochemical inactivation of duck hepatitis B virus in human platelet concentrates: a model of surrogate human hepatitis B virus infectivity

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Dramatic improvements in viral inactivation with brominated psoralens, naphthalenes and anthracenes

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Inhibition by albumin of merocyanine 540-mediated photosensitization of platelets and viruses

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Red cell alterations associated with virucidal methylene blue phototreatment.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Inactivation of viruses in blood with aluminum phthalocyanine derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

Hypericin as an inactivator of infectious viruses in blood components.

1 reference

https://api.crossref.org/works/10.1016%2FS1246-7820%2801%2900117-3

7 January 2021

10.1016/S1246-7820(01)00117-3

Identifiers

DOI

1 reference

18 June 2017

1 reference

PubMed ID

11499954